An announcement from China Touyun Tech Group ( (HK:1332) ) is now available.
Touyun Biotech Group Limited has announced that its board of directors will meet on March 26, 2025, to approve the company’s annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and shareholder returns, potentially impacting its market position and investor relations.
More about China Touyun Tech Group
Touyun Biotech Group Limited operates within the biotechnology sector, focusing on developing and commercializing biotech products and services. The company is incorporated in Bermuda and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -5.79%
Average Trading Volume: 128,822
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$502.3M
For an in-depth examination of 1332 stock, go to TipRanks’ Stock Analysis page.